Cargando…
Hepatic cavernous hemangioma developed in non-small cell lung cancer patients after receiving Camrelizumab treatment: two case reports
PURPOSE: To report two cases of hepatic cavernous hemangioma, a rare complication, in patients with locally advanced and advanced non-squamous non-small cell lung cancer (NSCLC) treated with PD-1 inhibitors. Additionally, to share clinical experiences related to the management of this condition. MET...
Autores principales: | Jin, Yonglong, Xu, Jinpeng, Zhuang, Dunmin, Dong, Lina, Sun, Yang, Zhao, Lin, Xiao, Wenjing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435320/ https://www.ncbi.nlm.nih.gov/pubmed/37601678 http://dx.doi.org/10.3389/fonc.2023.1221309 |
Ejemplares similares
-
Diagnostic Imaging Methods and Comparative Analysis of Orbital Cavernous Hemangioma
por: Zhang, Li, et al.
Publicado: (2020) -
An atypical case of hepatic cavernous hemangioma
por: Brogna, Alfio, et al.
Publicado: (2009) -
Multisession CyberKnife Radiosurgery for Orbital Cavernous Hemangiomas
por: Sasaki, Yusuke, et al.
Publicado: (2021) -
Microwave ablation plus camrelizumab monotherapy or combination therapy in non-small cell lung cancer
por: Huang, Yahan, et al.
Publicado: (2022) -
Hepatic sclerosed hemangioma and sclerosing cavernous hemangioma: a radiological study
por: Jia, Cuiyu, et al.
Publicado: (2021)